Wedemeyer H, Alexandrov A, Bogo-molov P, et al. Interim results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection. AASLD 2017, abstract 37.
128.000 nieuwe kankerpatiënten in 2023: meer diagnoses in vroeg stadium
feb 2024 | Borstkanker, Dermato-oncologie, Gynaecologische oncologie, Hoofd-halsoncologie, Longoncologie, Maag-darm-leveroncologie, Uro-oncologie